Freiman Paul E.
Insider CIK 1410074 · NBY Director · NTRP See Remarks, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SDEV Stablecoin Development Cor | A Award deriv | 2026-03-31 | 2026-04-21 | 140,000 | — | $0 | 140,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2024-05-28 | 2024-05-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2023-06-09 | 2023-06-13 | 858 | — | $0 | 858 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | M Exercise deriv | 2023-05-11 | 2023-05-15 | 858 | — | $0 | 0 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | M Exercise | 2023-05-11 | 2023-05-15 | 858 | — | $0 | 1,716 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | M Exercise deriv | 2022-05-21 | 2022-05-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | M Exercise | 2022-05-21 | 2022-05-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2022-05-11 | 2022-05-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2021-05-21 | 2021-05-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2020-05-26 | 2020-05-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2019-05-30 | 2019-10-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2018-05-31 | 2018-06-04 | 20,000 | — | $0 | 62,697 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2017-01-03 | 2017-01-04 | 25,916 | — | $0 | 67,097 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2017-01-03 | 2017-01-04 | 25,916 | — | $0 | 67,097 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2016-01-04 | 2016-01-06 | 26,835 | — | $0 | 41,181 | SEC↗ |
| NTRP Neurotrope, Inc. | A Award deriv | 2015-11-19 | 2015-11-20 | 200,000 | — | $0 | 200,000 | SEC↗ |
| NTRP Neurotrope, Inc. | P Buy deriv | 2015-11-13 | 2015-11-17 | 166,667 | — | $0 | 166,667 | SEC↗ |
| NTRP Neurotrope, Inc. | P Buy deriv | 2015-11-13 | 2015-11-17 | 166,667 | — | $0 | 166,667 | SEC↗ |
| NTRP Neurotrope, Inc. | P Buy deriv | 2015-11-13 | 2015-11-17 | 166,667 | — | $0 | 166,667 | SEC↗ |
| NTRP Neurotrope, Inc. | P Buy deriv | 2015-11-13 | 2015-11-17 | 166,667 | — | $0 | 166,667 | SEC↗ |
| NTRP Neurotrope, Inc. | P Buy deriv | 2015-11-13 | 2015-11-17 | 1,667 | — | $0 | 166,667 | SEC↗ |
| NTRP Neurotrope, Inc. | P Buy deriv | 2015-11-13 | 2015-11-17 | 166,667 | — | $0 | 166,667 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2015-01-02 | 2015-01-06 | 121,144 | — | $0 | 358,654 | SEC↗ |
| NTRP Neurotrope, Inc. | A Award deriv | 2014-09-12 | 2014-09-16 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2014-01-02 | 2014-01-09 | 15,000 | — | $0 | 237,510 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2013-01-02 | 2013-01-15 | 15,000 | — | $0 | 222,510 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2012-01-03 | 2012-01-05 | 67,510 | — | $0 | 67,510 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | X Exercise deriv | 2011-12-29 | 2012-01-05 | 30,000 | $0.20 | $6.0K | 30,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | X Exercise | 2011-12-29 | 2012-01-05 | 30,000 | $0.20 | $6.0K | 45,137 | SEC↗ |